Searched for
JUBILANT PHARMOVA SHARE PRICE
Mid-cap stocks: Time for a change of stance? 6 mid-caps from different sectors with an upside potential up to 29%Sometimes the real market story is not in the headline index. The Nifty and Sensex can be under pressure, and yet, below them, mid- and sma...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- Jubilant Pharmova among 4 stocks flashing bullish signals, hinting at a possible uptrendFour Nifty500 stocks featured in StockEdge’s White Marubozu scan on August 10, signalling strong buying pressure. Syrma SGS, Cemindia Proje...
- Avenue Supermarts among 4 stocks showing bullish RSI upswingOn August 10, four Nifty500 stocks showed strengthening RSI momentum after crossing above 50, signalling potential upward movement. Avenue ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Market wrap: Titan Company, Bajaj Finance, SBI among top gainers and losers on Nifty and Sensex on MondayIndian benchmark indices ended largely flat on Monday as rising crude prices and Middle East uncertainty offset optimism from softer US job...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of upto 30%Around three months back, there was a trade which was taking place on the street, “sell-software-services-stocks”. Today there are signs th...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Defence stocks: Time to change strategy? 18 stocks with downside and upside potential from minus 26% to plus 26%When a stock remains in the red for several months, investors naturally begin questioning the investment. Imagine a shipbuilder remaining w...
- Two Trades for Today: A leading IT company for a gain of 6.4%, a mid-cap QSR stock for a rise of almost 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Q1 Results Tracker: Tata Motors, Vodafone Idea among 2,045 companies set to announce earnings this weekGoldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...
- For medium- to long-term investors seeking sustainable growth: 5 large- and mid-caps with upside potential of up to 28%When a market starts to recover, as it is these days, the temptation is to chase whatever is running the fastest (essentially momentum). Bu...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 23%Sentiment is a fickle thing and can change before you know it. And by the time you figure out why, the market would have moved on. So, whil...
- These large and mid-cap stocks can give more than 20% return in 1 year, according to analystsWhenever there is a correction or volatility, just ask one question: Is it an opportunity, or should one be wary? We are raising this issue...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Two Trades for Today: A top food service company and a mid-cap pharma stock, both for an upmove of about 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
Load More
